Literature DB >> 15266404

Challenges to the measurement of health-related quality of life in children receiving cancer therapy.

Paul C Nathan1, William Furlong, Ronald D Barr.   

Abstract

Measures of health-related quality of life (HRQL) assess those areas of a patient's functioning that are affected by their cancer and its therapy. Although HRQL measures are integrated frequently into studies of survivors of childhood cancer, their use in the assessment of children receiving therapy has been limited by several methodological challenges. These arise from issues specific to measuring HRQL in young children, who comprise a large proportion of the pediatric oncology population, and from issues associated with assessing HRQL during therapy, when the patient's health status is in constant flux. This study summarizes the commonly used HRQL measures, and examines factors that impact their broad application. These include the influence of developmental changes on the content and format of HRQL measures, the role of proxy assessors, the important characteristics of measurement tools used to assess patients receiving active therapy, and the issues related to the ideal timing of serial HRQL assessments in prospective trials. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15266404     DOI: 10.1002/pbc.20096

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Parental perceptions of health-related quality of life in children with leukemia in the second week after the diagnosis: a quantitative model.

Authors:  Marta Tremolada; Sabrina Bonichini; Gianmarco Altoè; Marta Pillon; Modesto Carli; Thomas S Weisner
Journal:  Support Care Cancer       Date:  2010-03-13       Impact factor: 3.603

2.  Symptom assessment in children receiving cancer therapy: the parents' perspective.

Authors:  L Lee Dupuis; Cindy Milne-Wren; Marilyn Cassidy; Maru Barrera; Carol Portwine; Donna L Johnston; Mariana Pradier Silva; Cathryn Sibbald; Michael Leaker; Stacey Routh; Lillian Sung
Journal:  Support Care Cancer       Date:  2009-06-10       Impact factor: 3.603

3.  Health-related quality of life among children with cancer in Hyderabad, India.

Authors:  Susmitha Chirivella; Senthil Rajappa; Sudha Sinha; Tim Eden; Ronald D Barr
Journal:  Indian J Pediatr       Date:  2009-12       Impact factor: 1.967

Review 4.  Clinical trials in pediatric neuro-oncology: what is missing and how we can improve.

Authors:  Lennox Byer; Cassie Kline; Sabine Mueller
Journal:  CNS Oncol       Date:  2016-09-12

5.  Health-related quality of life in adolescents at the time of diagnosis with osteosarcoma or acute myeloid leukemia.

Authors:  Pamela S Hinds; Catherine A Billups; Xueyuan Cao; Jami S Gattuso; Elizabeth Burghen; Nancy West; Jeffrey E Rubnitz; Najat C Daw
Journal:  Eur J Oncol Nurs       Date:  2008-10-15       Impact factor: 2.398

6.  Assessment of health-related quality of life among parents of children with solid tumors in Serbia.

Authors:  Vesna Ilic; Marina Nikitovic; Gorica Maric; Aleksa Jovanovic; Lejla Paripovic; Jelena Bokun; Dragana Stanic; Marija Popovic Vukovic; Darija Kisic Tepavcevic; Tatjana Pekmezovic
Journal:  Support Care Cancer       Date:  2020-02-10       Impact factor: 3.603

7.  Malnutrition is associated with worse health-related quality of life in children with cancer.

Authors:  Aeltsje Brinksma; Robbert Sanderman; Petrie F Roodbol; Esther Sulkers; Johannes G M Burgerhof; Eveline S J M de Bont; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

Review 8.  Nutritional Status of Pediatric Cancer Patients at Diagnosis and Correlations with Treatment, Clinical Outcome and the Long-Term Growth and Health of Survivors.

Authors:  Vassiliki Diakatou; Tonia Vassilakou
Journal:  Children (Basel)       Date:  2020-11-07

9.  Identification of paediatric cancer patients with poor quality of life.

Authors:  L Sung; R J Klaassen; D Dix; S Pritchard; R Yanofsky; B Dzolganovski; R Almeida; A Klassen
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.